|
|
SPOT ON
|
|
Antithrombotic triple therapy
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
New data on HPV vaccines
Tight blood sugar control in type 2 diabetes?
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
UKPDS follow-up: consequences for the treatment of diabetes
INTANZA: a new intradermal influenza vaccine
Generics in the patent trap
|
|
|
IN BRIEF
|
|
Quality tests of citalopram preparations (CIPRAMIL, generics)
|
|
|
CURRENT ADR NETWORK REPORT
|
|
|
Paraesthesia due to angiotensin-II receptor antagonists
|
|
|
SIDE EFFECTS
|
|
Omalizumab (XOLAIR): cardiovascular ADR
|
|